Loading insider details...
Beta
Latest Form 4 (May 21, 2026): Grant/Award of 41,800 INO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 41,800 | n/a |
| Feb 27, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 972 | n/a |
| May 21, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 2,167 | n/a |
| Feb 28, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 972 | n/a |
| May 22, 2024 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 2,917 | n/a |
| May 16, 2024 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 2,166 | n/a |
| Feb 28, 2024 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 972 | n/a |
| May 16, 2023 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 19,000 | n/a |
| Mar 13, 2023 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 11,666 | n/a |
| Feb 28, 2023 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 11,667 | n/a |